LeMaitre Vascular Announces Q2 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Lemaitre Vascular (LMAT) Tops Q2 EPS by 16c, Revenue Beat; Offers 3Q EPS/Revenue Guidance Above Consensus
July 23, 2020 4:29 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.17, $0.16 better than the analyst estimate of $0.01. Revenue for the quarter came in at $24.9 million versus the consensus estimate of $17.12 million.
Q2 2020 Results
Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019Op. income of $4.9mm,... More